Literature DB >> 26771662

Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda.

Carina Marquez1, Gabriel Chamie, Jane Achan, Anne F Luetkemeyer, Mary Kyohere, Jaffer Okiring, Grant Dorsey, Moses R Kamya, Edwin D Charlebois, Diane V Havlir.   

Abstract

BACKGROUND: In high tuberculosis (TB) burden countries, a significant proportion of the latent TB reservoir is established by the age 5 years. There are critical knowledge gaps in our understanding of the age-specific prevalence of TB infection and the influence of HIV exposure on TB infection in the first 5 years of life among HIV-uninfected children in sub-Saharan Africa.
METHODS: We measured TB infection with the Quantiferon Gold-in-Tube (QFT) and tuberculin skin tests (TST) in 447 children ≤60 months and their 284 HIV-infected and IV-uninfected mothers in rural Uganda.
RESULTS: The overall prevalence of TB infection in children ≤60 months by TST was 24% (95% confidence intervals [CI]: 19.9-27.9). The prevalence of TST positivity was highest among children in their first year of life (36%; 95% CI: 26.0-45.9) and declined with age to 19% at 36-60 months of age, χ test for trend P = 0.014. In contrast, 4% (95% CI: 1.9-5.87%) of children had a positive QFT, and there was no trend detected with age, P = 0.576. QFT positivity was detected as early as 5 months. HIV-exposed uninfected children had significantly higher odds of TB infection by QFT (odds ratio [OR]: 21.2; P = 0.008; 95% CI: 2.2-204.7) or positive TST or QFT (OR, 2.4; P = 0.020; 95% CI: 1.2-5.1) compared with HIV-unexposed uninfected children, adjusting for age, BCG vaccination and a positive maternal TST or QFT.
CONCLUSIONS: An appreciable prevalence of TB infection was detected in early childhood. HIV-exposed uninfected children have a higher risk for TB infection compared with children born to HIV-uninfected mothers.

Entities:  

Mesh:

Year:  2016        PMID: 26771662      PMCID: PMC4829461          DOI: 10.1097/INF.0000000000001062

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  40 in total

1.  Progress and challenges in childhood tuberculosis.

Authors:  Ben J Marais; Stephen M Graham; Markus Maeurer; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2013-03-24       Impact factor: 25.071

2.  Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis.

Authors:  I Malhotra; P Mungai; A Wamachi; J Kioko; J H Ouma; J W Kazura; C L King
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

3.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

4.  Influence of maternal filariasis on childhood infection and immunity to Wuchereria bancrofti in Kenya.

Authors:  Indu Malhotra; John H Ouma; Alex Wamachi; John Kioko; Peter Mungai; Malik Njzovu; James W Kazura; Christopher L King
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 5.  Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities.

Authors:  D A Lewinsohn; M L Gennaro; L Scholvinck; D M Lewinsohn
Journal:  Int J Tuberc Lung Dis       Date:  2004-05       Impact factor: 2.373

6.  Highly discordant T cell responses in individuals with recent exposure to household tuberculosis.

Authors:  A C Hesseling; A M Mandalakas; H L Kirchner; N N Chegou; B J Marais; K Stanley; X Zhu; G Black; N Beyers; G Walzl
Journal:  Thorax       Date:  2008-08-05       Impact factor: 9.139

7.  Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis.

Authors:  V V Banu Rekha; K Jagarajamma; F Wares; V Chandrasekaran; S Swaminathan
Journal:  Int J Tuberc Lung Dis       Date:  2009-12       Impact factor: 2.373

8.  Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.

Authors:  M E Villarino; W Burman; Y C Wang; L Lundergan; A Catanzaro; N Bock; C Jones; C Nolan
Journal:  JAMA       Date:  1999-01-13       Impact factor: 56.272

9.  Factors associated with malaria parasitaemia, malnutrition, and anaemia among HIV-exposed and unexposed Ugandan infants: a cross-sectional survey.

Authors:  Beth Osterbauer; James Kapisi; Victor Bigira; Florence Mwangwa; Stephen Kinara; Moses R Kamya; Grant Dorsey
Journal:  Malar J       Date:  2012-12-27       Impact factor: 2.979

10.  Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa.

Authors:  Kwame Shanaube; Charalambos Sismanidis; Helen Ayles; Nulda Beyers; Ab Schaap; Katherine-Anne Lawrence; Annie Barker; Peter Godfrey-Faussett
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more
  16 in total

Review 1.  Tuberculosis in Children.

Authors:  Tania A Thomas
Journal:  Pediatr Clin North Am       Date:  2017-08       Impact factor: 3.278

Review 2.  Tuberculosis susceptibility and protection in children.

Authors:  Robindra Basu Roy; Elizabeth Whittaker; James A Seddon; Beate Kampmann
Journal:  Lancet Infect Dis       Date:  2018-10-12       Impact factor: 25.071

3.  A Randomized Controlled Trial of Isoniazid to Prevent Mycobacterium tuberculosis Infection in Kenyan Human Immunodeficiency Virus-Exposed Uninfected Infants.

Authors:  Sylvia M LaCourse; Barbra A Richardson; John Kinuthia; A J Warr; Elizabeth Maleche-Obimbo; Daniel Matemo; Lisa M Cranmer; Jerphason Mecha; Jaclyn N Escudero; Thomas R Hawn; Grace John-Stewart
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 9.079

4.  High Incidence of Tuberculosis Infection in HIV-exposed Children Exiting an Isoniazid Preventive Therapy Trial.

Authors:  Lisa M Cranmer; Heather R Draper; Anna M Mandalakas; Soyeon Kim; George McSherry; Emma Krezinski; Joan Coetzee; Charles Mitchell; Sharon Nachman; Mercia van der Linde; Mark F Cotton; Anneke C Hesseling
Journal:  Pediatr Infect Dis J       Date:  2018-10       Impact factor: 2.129

5.  Interferon Gamma Release Assay and Tuberculin Skin Test Performance in Pregnant Women Living With and Without HIV.

Authors:  Samantha R Kaplan; Jaclyn N Escudero; Jerphason Mecha; Barbra A Richardson; Elizabeth Maleche-Obimbo; Daniel Matemo; John Kinuthia; Grace C John-Stewart; Sylvia M LaCourse
Journal:  J Acquir Immune Defic Syndr       Date:  2022-01-01       Impact factor: 3.771

Review 6.  What do we know about children living with HIV-infected or AIDS-ill adults in Sub-Saharan Africa? A systematic review of the literature.

Authors:  Rachel E Goldberg; Susan E Short
Journal:  AIDS Care       Date:  2016-03

7.  Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.

Authors:  Tan N Doan; Damon P Eisen; Morgan T Rose; Andrew Slack; Grace Stearnes; Emma S McBryde
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

8.  Gaps in the Child Tuberculosis Care Cascade in 32 Rural Communities in Uganda and Kenya.

Authors:  Florence Mwangwa; Gabriel Chamie; Dalsone Kwarisiima; James Ayieko; Asiphas Owaraganise; Theodore D Ruel; Albert Plenty; Khai Hoan Tram; Tamara D Clark; Craig R Cohen; Elizabeth A Bukusi; Maya Petersen; Moses R Kamya; Edwin D Charlebois; Diane V Havlir; Carina Marquez
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2017-12

9.  Estimating Tuberculin Skin Test Reactions among Children and Teenagers Who Received the Bacillus Calmette-Guerin Vaccination at Birth: A Meta-analysis.

Authors:  Mohammad Sadegh Rezai; Siavosh Abedi; Mahdi Afshari; Mahmood Moosazadeh
Journal:  Osong Public Health Res Perspect       Date:  2017-02-28

10.  Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent M. tuberculosis infection in HIV-exposed uninfected children.

Authors:  Sylvia M LaCourse; Barbra A Richardson; John Kinuthia; A J Warr; Elizabeth Maleche-Obimbo; Daniel Matemo; Lisa M Cranmer; Jaclyn N Escudero; Thomas R Hawn; Grace C John-Stewart
Journal:  BMJ Open       Date:  2020-01-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.